stockrow
Friday 6 November 2026
Export HQY’s income statement to Excel — free account
HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025.
- Revenue
- +7.64%
- EPS
- +14.5%
- Free cash flow
- −3.44%
- Total debt
- −7.53%
Quarter to July 2026, against a year earlier
103.64
0.18
+0.17%
Follow HQY
Alert me
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
42.80 | 34.97 | 30.49 | 36.06 |
P/S ratio |
6.30 | 5.71 | 5.18 | 6.16 | |
P/FCF ratio |
22.43 | 18.37 | 15.70 | 19.21 | |
P/Operating CF |
58.69 | 63.60 | 71.00 | 61.61 | |
P/B ratio |
3.81 | 3.56 | 3.38 | 4.22 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
6.84 | 6.21 | 5.70 | 6.67 | |
EV/EBITDA |
19.62 | 17.06 | 15.32 | 17.81 | |
EV/Operating CF |
21.27 | 17.84 | 15.55 | 18.53 | |
EV/FCF |
24.33 | 19.97 | 17.28 | 20.80 | |
Quick Ratio |
3.49 | 2.82 | 2.85 | 2.46 | |
Current Ratio |
4.13 | 3.27 | 3.44 | 2.99 | |
Net Debt/EBITDA |
5.71 | 5.80 | 4.80 | 4.79 | |
Debt/Assets |
28.90% | 28.32% | 28.51% | 28.46% | |
Debt/Equity |
0.46 | 0.45 | 0.46 | 0.47 | |
Asset Turnover |
0.37 | 0.38 | 0.40 | 0.41 | |
Operating CF/Net income |
2.68 | 2.37 | 1.40 | 2.07 | |
Capex/Depreciation |
(0.29) | (0.26) | (0.43) | (0.37) | |
Interest Coverage |
5.60 | 5.36 | 8.18 | 7.83 | |
Research and Development Expense of Revenue |
20.46% | 21.03% | 19.11% | 21.08% | |
Selling, General and Administrative Expense of Revenue |
17.16% | 17.47% | 16.34% | 16.56% | |
Intangible Assets out of Total Assets |
0.82 | 0.81 | 0.82 | 0.82 | |
Share Based Compensation of Revenue |
6.38% | 5.71% | 5.47% | 6.33% | |
Graham Net Nets |
(0.09) | (0.10) | (0.11) | (0.10) | |
Graham Number |
35.13 | 37.02 | 38.31 | 38.71 | |
Earnings Yield |
2.34% | 2.86% | 3.28% | 2.77% | |
Free Cash Flow Yield |
4.46% | 5.44% | 6.37% | 5.21% | |
Revenue per Share |
3.75 | 3.88 | 4.20 | 4.21 | |
Operating CF per Share |
1.61 | 1.37 | 1.16 | 1.63 | |
Capex per Share |
(0.13) | (0.12) | (0.19) | (0.19) | |
Free Cash Flow per Share |
1.48 | 1.25 | 0.96 | 1.44 | |
Cash per Share |
3.60 | 3.70 | 3.14 | 3.07 | |
Shareholders Equity per Share |
24.82 | 24.46 | 24.25 | 23.87 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
24.82 | 24.46 | 24.25 | 23.87 | |
Free Cash Flow |
127.19 | 107.84 | 81.23 | 120.39 | |
Working Capital |
378.08 | 355.43 | 330.79 | 306.43 | |
Capital Expenditures |
(11.38) | (10.07) | (16.29) | (15.77) | |
Net Current Asset Value |
(765.33) | (760.85) | (792.26) | (821.05) | |
EV/EBIT |
30.06 | 25.29 | 22.26 | 25.84 | |
Capex to Sales |
0.04 | 0.03 | 0.05 | 0.05 | |
Price to Operating Income |
27.71 | 23.26 | 20.23 | 23.87 | |
| Other line items | |||||
Average Receivables |
108.98 | 120.85 | 119.13 | 116.68 | |
Average Payables |
14.95 | 13.26 | 13.86 | 9.10 | |
Average Assets |
3,443.20 | 3,414.44 | 3,361.23 | 3,344.02 | |
Average Common Equity |
2,129.36 | 2,111.05 | 2,085.60 | 2,068.27 |
Columns are period end dates